2023 Year in Review: High-Flow Nasal Cannula for COVID-19

被引：1

作者：

Davis, Michael D. ^{[1
]}

机构：

[1] Indiana Univ Sch Med, Riley Hosp Children, Wells Ctr Pediat Res Pulmonol Allergy & Sleep Med, Indianapolis, IN 46202 USA

来源：

RESPIRATORY CARE | 2024年 / 69卷 / 12期

关键词：

COVID-19; SARS-CoV-2; high-flow nasal; cannula; HFNC; respiratory oxygenation index; ROX; fugitive aerosols; OXYGEN; DELIVERY; AEROSOLS; SUPPORT;

D O I：

10.4187/respcare.12580

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

COVID-19, caused by SARS-CoV-2 infection, led to a pandemic of acute respiratory illness that is ongoing. High-flow nasal cannula (HFNC) is a commonly used form of respiratory support during acute respiratory distress and is used to treat patients with COVID-19 in many centers. Due to the novel nature of COVID-19 at the onset of the pandemic, evidence to support the use and best practices of HFNC for treating patients with COVID-19 was lacking. This is a review of key peer-reviewed manuscripts from 2022-2023 discussing the efficacy and best practices for using HFNC for patients with COVID-19. Efficacy of HFNC for COVID-19, the use of the respiratory oxygenation index to guide HFNC for COVID-19, and concerns of generated/fugitive aerosols when using HFNC for COVID-19 are emphasized.

引用

页码：1587 / 1591

页数：5

共 29 条

[1] Early Variation of ROX Index Predicts High-Flow Nasal Cannula Outcome in Awake Subjects With Severe Hypoxemic COVID-19 [J].

Abroug, Fekri ;

Hammouda, Zeineb ;

Lahmar, Manel ;

Nouira, Wiem ;

Maatouk, Syrine ;

Youssef, Sourour Belhaj ;

Dachraoui, Fahmi ;

Brochard, Laurent ;

Ouanes-Besbes, Lamia .

RESPIRATORY CARE, 2023, 68 (01) :110-113

[2] COVID-19: minimising risk to healthcare workers during aerosol-producing respiratory therapy using an innovative constant flow canopy [J].

Adir, Yochai ;

Segol, Ori ;

Kompaniets, Dmitry ;

Ziso, Hadas ;

Yaffe, Yechiam ;

Bergman, Irina ;

Hassidov, Erez ;

Eden, Arieh .

EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (05)

[3]

Agarwal A, 2020, CAN J ANESTH, V67, P1217, DOI 10.1007/s12630-020-01740-2

[4]

[Anonymous], 2021, CDC COVID data tracker: multisystem inflammatory syndrome in children (MIS -C)

[5] Effectiveness of high-flow nasal cannula therapy on clinical outcomes in adults with COVID-19: A systematic review [J].

Arruda, Daiana Goncalves ;

Kieling, George Alvicio ;

Melo-Diaz, Lucelia Luna .

CANADIAN JOURNAL OF RESPIRATORY THERAPY, 2023, 59 (01) :52-65

[6]

Benge Cassandra D, 2020, Fed Pract, V37, P160

[7] Guidance on nebulization during the current COVID-19 pandemic [J].

Cazzola, Mario ;

Ora, Josuel ;

Bianco, Andrea ;

Rogliani, Paola ;

Matera, Maria Gabriella .

RESPIRATORY MEDICINE, 2021, 176

[8] The Effects of Gas Humidification with High-Flow Nasal Cannula on Cultured Human Airway Epithelial Cells [J].

Chidekel, Aaron ;

Zhu, Yan ;

Wang, Jordan ;

Mosko, John J. ;

Rodriguez, Elena ;

Shaffer, Thomas H. .

PULMONARY MEDICINE, 2012, 2012

[9] Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients [J].

Corley, A. ;

Caruana, L. R. ;

Barnett, A. G. ;

Tronstad, O. ;

Fraser, J. F. .

BRITISH JOURNAL OF ANAESTHESIA, 2011, 107 (06) :998-1004

[10] High-Flow Nasal Cannula and COVID-19: A Clinical Review [J].

Crimi, Claudia ;

Pierucci, Paola ;

Renda, Teresa ;

Pisani, Lara ;

Carlucci, Annalisa .

RESPIRATORY CARE, 2022, 67 (02) :227-240

← 1 2 3 →